Possible Risk Factors for Candida Esophagitis in Immunocompetent Individuals

被引:19
|
作者
Nassar, Yousef [1 ]
Eljabbour, Tony [2 ]
Lee, Hwajeong [2 ]
Batool, Asra [3 ]
机构
[1] Albany Med Ctr, Dept Med, 43 New Scotland Ave, Albany, NY 12208 USA
[2] Albany Med Ctr, Dept Pathol, 43 New Scotland Ave, Albany, NY 12208 USA
[3] Albany Med Ctr, Dept Med, Div Gastroenterol, 43 New Scotland Ave, Albany, NY 12208 USA
关键词
Candida esophagitis; Healthy; Esophageal candidiasis; Proton pump inhibitors;
D O I
10.14740/gr1019w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Candida esophagitis (CE) is a condition typically diagnosed in patients who are immunocompromised. Risk factors leading to the development of CE in immunocompetent patients have not been entirely elucidated. This study set out to identify risk factors associated with the development of CE in immunocompetent patients. Methods: This study was a single-center retrospective chart review. Patients diagnosed with CE confirmed by endoscopic biopsy or brushings at our hospital between 2007 and 2017 were reviewed. The medical histories, endoscopy reports and pathology results were noted. Abdominal pain, heartburn, dysphagia and odynophagia were the common indications for endoscopy. A total of 241 patients were identified as having been diagnosed with CE by endoscopic brushing or biopsy. Of these patients, 161 were excluded due to the presence of immunocompromising and 80 patients were included who had no underlying immunocompromising conditions. Results: Eighty patients with CE satisfied the inclusion criteria. The mean age of patients at the time of diagnosis was 39.8 years old (95% CI: 34.9 - 44.7). The incidences in men and women were similar in this study (49% women and 51% men). Of these patients, 56 (70%) (95% CI: 59-80%; P < 0.005) were taking proton pump inhibitors (PPIs). Fifteen patients (19%) had a previous upper endoscopy with evidence of reflux esophagitis, and they were all treated with PPIs and subsequently found to have CE on repeat upper endoscopy with a mean of 21.6 months of PPI treatment. There were 16 (20%) patients without any attributable risk factor and were completely healthy. Conclusions: CE is an opportunistic infection typically seen in immunocompromised. We report incidence of CE in immunocompetent patients. In our cohort of immunocompetent patients, PPI use was the most common risk factor associated with the development of CE. This could be related to hypochlorhydria resulting from PPI use. However, the cause remains unclear in some patients.
引用
收藏
页码:195 / 199
页数:5
相关论文
共 50 条
  • [21] Associations of diet and lifestyle factors with common volatile organic compounds in exhaled breath of average-risk individuals
    Krilaviciute, Agne
    Leja, Marcis
    Kopp-Schneider, Annette
    Barash, Orna
    Khatib, Salam
    Amal, Haitham
    Broza, Yoav Y.
    Polaka, Inese
    Parshutin, Sergei
    Rudule, Aiga
    Haick, Hossam
    Brenner, Hermann
    JOURNAL OF BREATH RESEARCH, 2019, 13 (02)
  • [22] Eosinophilic esophagitis that develops during therapy with proton pump inhibitors : case series and possible mechanisms
    Orel, Rok
    Murch, Simon
    Dias, Jorge Amil
    Vandenplas, Yvan
    Homan, Matjaz
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2016, 79 (02) : 245 - 250
  • [23] The expression of the β-defensins hBD-2 and hBD-3 is differentially regulated by NF-κB and MAPK/AP-1 pathways in an in vitro model of Candida esophagitis
    Nadine Steubesand
    Karlheinz Kiehne
    Gabriele Brunke
    Rene Pahl
    Karina Reiss
    Karl-Heinz Herzig
    Sabine Schubert
    Stefan Schreiber
    Ulrich R Fölsch
    Philip Rosenstiel
    Alexander Arlt
    BMC Immunology, 10
  • [24] Immune recovery in HIV-infected patients after Candida esophagitis is impaired despite long-term antiretroviral therapy
    Stuehler, Claudia
    Bernardini, Claudia
    Elzi, Luigia
    Stoeckle, Marcel
    Zimmerli, Stefan
    Furrer, Hansjakob
    Gunthard, Huldrych F.
    Leibundgut-Landmann, Salome
    Battegay, Manuel
    Khanna, Nina
    AIDS, 2016, 30 (12) : 1923 - 1933
  • [25] GI risk and risk factors of NSAIDs
    Laine, Loren
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 47 : S60 - S66
  • [26] Analysis of risk factors for a high prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in asymptomatic individuals in rural Thailand
    Luvsansharay, Ulzii-Orshikh
    Hirai, Itaru
    Niki, Marie
    Sasaki, Tadahiro
    Makimoto, Kiyoko
    Komalamisra, Chalit
    Maipanich, Wanna
    Kusolsuk, Teera
    Sa-Nguankiat, Surapol
    Pubampen, Somchit
    Yamamoto, Yoshimasa
    JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 60 (05) : 619 - 624
  • [27] Impact of Meal Fatty Acid Composition on Postprandial Lipemia in Metabolically Healthy Adults and Individuals with Cardiovascular Disease Risk Factors: A Systematic Review
    Neumann, Hannah F.
    Egert, Sarah
    ADVANCES IN NUTRITION, 2022, 13 (01) : 193 - 207
  • [28] Recurring Candida albicans esophagitis in a HIV-infected patient undergoing long-term antiretroviral therapy, and with absent-negligible immunodeficiency
    Manfredi, Roberto
    Sabbatani, Sergio
    Calza, Leonardo
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (06) : 605 - 609
  • [29] PPIs as possible risk factor for copper deficiency myelopathy
    Plantone, Domenico
    Renna, Rosaria
    Primiano, Guido
    Shukralla, Arif
    Koudriavtseva, Tatiana
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 349 (1-2) : 258 - 259
  • [30] Eosinophilic Esophagitis Patients Are Not at Increased Risk of Severe COVID-19: A Report From a Global Registry
    Zevit, Noam
    Chehade, Mirna
    Leung, John
    Marderfeld, Luba
    Dellon, Evan S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (01) : 143 - +